Uptake of core outcome sets by clinical trialists in China: a protocol.

Qiu, Ruijin, Fan, Xiaodan, Wang, Wenhui, Clarke, Mike, Chen, Zhuo, Liu, Shuling, Williamson, Paula ORCID: 0000-0001-9802-6636 and Shang, Hongcai (2024) Uptake of core outcome sets by clinical trialists in China: a protocol. F1000Research, 12. p. 1030.

Access the full-text of this item by clicking on the Open Access link.

Official URL: http://dx.doi.org/10.12688/f1000research.139282.2

Abstract

<h4>Background</h4>The concept of core outcome sets (COS) has been introduced in China for about 10 years. In recent years, some Chinese researchers also committed to developing COS, though the majority of COS are ongoing. However, there were more than 500 published COS for research in the COMET database by 2020. The extent of availability of COS for the top 25 diseases with the highest burden in China is unknown. In addition, the uptake of COS in clinical trials for these diseases is unknown, along with the knowledge, perceptions, and views of the clinical trialist community in China on the use of COS in relation to choosing outcomes for their research.<h4>Methods</h4>The main burden of disease in China will be identified. Then we will search the COMET database to identify if there are ongoing or completed relevant COS research A COS published since 2012 would be preferred to one published before 2012 for the analysis of COS uptake if one meets the eligibility criteria. We will extract scopes of published eligible COS, including condition, population, interventions, and core outcomes. Then we will search the Chinese Clinical Trial Registry using disease names for each disease that has a published COS. We will assess the overlap in scope between clinical trials and COS. Then we will conduct an online survey and semi-structured interviews to identify the knowledge and perceptions of COS among primary investigators of included clinical trials.<h4>Discussion</h4>This research will fill in gaps between COS and the burden of disease in China. Understanding clinical trialists'knowledge and perceptions of COS may help dissemination and application of COS in the future.<h4>Trial registration</h4>This research is registered in Core Outcome Measures in Effectiveness: https://www.comet-initiative.org/Studies/Details/2563.

Item Type:	Article
Uncontrolled Keywords:	Endpoint Determination, Consensus, Research Design, Delphi Technique, China, Clinical Trials as Topic, Outcome Assessment, Health Care
Divisions:	Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Population Health
Depositing User:	Symplectic Admin
Date Deposited:	23 Apr 2024 09:02
Last Modified:	23 Apr 2024 09:03
DOI:	10.12688/f1000research.139282.2
Open Access URL:	https://doi.org/10.12688/f1000research.139282.2
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3180538